TIMO HILDÉN APPOINTED CEO OF ICARE FINLAND

Mon, Feb 20, 2012 11:45 CET

Revenio Group Corporation STOCK EXCHANGE RELEASE 20.2.2012 at 12.45.

Timo Hildén, 53, M.Sc. (Econ. & Bus.Adm.) has been appointed CEO of Icare Finland, a subsidiary in the Health Care segment of Revenio Group Corporation, as of 9 April 2012. He has held several managerial positions within the health care sector industry, most recently as Thermo Fisher Scientific Oy's CEO and director of global business for liquid handling instruments.

Olli-Pekka Salovaara, the president and CEO of Revenio Group Corporation:

“Timo Hildén has a remarkable career in the health care and life science sectors. Timo's broad international experience, expertise in the medical field and personal qualities will strengthen the Icare Finland organization even further. Timo's task is to significantly increase the company's net sales in new market segments and broaden the company's product assortment in the long run."

Revenio Group Corporation

Olli-Pekka Salovaara

President and CEO

For further information, please contact:

Olli-Pekka Salovaara, President and CEO, mobile +358 (0) 40 5675520

olli-pekka.salovaara@revenio.fi

http://www.reveniogroup.fi/en/Investors/Public+Insiders

DISTRIBUTION:

NASDAQ OMX Helsinki

Financial Supervisory Authority (FIN-FSA)

Key media

www.revenio.fi

Revenio Group Corporation, the parent company of the Finnish conglomerate Revenio Group, is listed on the NASDAQ OMX Helsinki. Revenio Group Corporation’s subsidiaries share a focus on Finnish specialist expertise and export-based operations.

Revenio Group consists of six independent subsidiaries in five business segments. These subsidiaries are Done Logistics Oy, Done Software Solutions Oy, Icare Finland Oy, Boomeranger Boats Oy, FLS Finland Oy and Midas Touch Oy.